Phase 2 Multicenter, Double-Blind, Placebo Controlled, Efficacy, Safety, and Pharmacokinetic Study of 2 Doses of CXA-10 on Stable Background Therapy in Subjects With Pulmonary Arterial Hypertension
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 17 Apr 2018
At a glance
- Drugs CXA 10 (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- Sponsors Complexa
- 22 Feb 2018 Status changed from planning to not yet recruiting.
- 26 Jul 2017 According to Complexa media release, this trial will initiate in the first half of 2018.
- 20 Nov 2015 New trial record